C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
C MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
批准号:
6375935
负责人:
CHI V. DANG
金额:
$40.95万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-09-01 至 2005-07-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION: (Adapted from applicant's abstract) The c-myc gene is one of the
most highly altered oncogene in human cancers. In contrast to normal cells, in
which c-myc expression is regulated, expression of the c-myc gene is
constitutive in many types of human cancers. The c-Myc protein dimerizes with
Max to bind specific DNA sites and regulate transcription. To further
understand the mechanisms of transformation by c-Myc, he sought to identify
c-Myc target genes. In the past funding period, his strategy using
representational difference analysis was successful in identifying a number of
biologically relevant Myc target genes. Taking a reductionistic approach, he
discovered that c-Myc regulates lactate dehydrogenase A expression and causes
enhanced glycolysis, a phenotype that is prevalent among cancers. He also
discovered two novel Myc target genes, Rcl and JP1, which induce
anchorage-independent growth resembling the phenotype induced by c-Myc.
Although the products of these Myc target genes partially recapitulate Myc
function, their biochemical functions are unknown. His strategy has yielded
important insights; however, it has become apparent that a focused,
reductionistic approach does not take into account the collaborations among
c-Myc target genes to induce specific c-Myc mediated phenotypes. Hence, he has
taken an integrative approach and have begun to use cDNA microarray analyses to
identify sets of genes that are either up-regulated or down-regulated by c-Myc.
Through this strategy, he will identify additional links between c-Myc, its
target genes and Myc mediated phenotypes. He is in a unique position to define
gene expression patterns that are related to c-Myc overexpression and hope that
this information will help in the molecular classification of cancers. To reach
the long term goal of understanding the transcription program induced by c-Myc
in human cancers, he sets the following aims: (1) To further characterize rcl
and JP1 and identify their biochemical functions; (2) To identify direct c-Myc
target genes using an inducible c-Myc system and to identify c-Myc target genes
that are regulated through histone acetylation or methylation; and (3) To
identify a subset of c-Myc transcriptional targets that is expressed
independently of tumor tissue type.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10205608
-
项目类别:
-
资助金额:$59.87万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10728412
-
项目类别:
-
资助金额:$46.22万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10623158
-
项目类别:
-
资助金额:$54.47万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
Defining metabolic adaptations within the PDAC "arid" tumor microenvironment
-
批准号:10396617
-
项目类别:
-
资助金额:$10.35万
-
财政年份:2021
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6474169
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6528030
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
MYC Oncogene Hubsite
-
批准号:6651086
-
项目类别:
-
资助金额:$6.6万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
FASEB conference on Hematological Malignancies
-
批准号:6359970
-
项目类别:
-
资助金额:$0.85万
-
财政年份:2001
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8710658
-
项目类别:
-
资助金额:$1.25万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9131243
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8402161
-
项目类别:
-
资助金额:$721.69万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8998395
-
项目类别:
-
资助金额:$797.55万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
DEVELOPMENTAL FUNDS (Core 002)
-
批准号:8998398
-
项目类别:
-
资助金额:$99.53万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
PLANNING AND EVALUATION (Core 001)
-
批准号:8998397
-
项目类别:
-
资助金额:$5.27万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9338556
-
项目类别:
-
资助金额:$50.0万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8789009
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:8300800
-
项目类别:
-
资助金额:$772.51万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
Abramson Cancer Center Support Grant
-
批准号:9378876
-
项目类别:
-
资助金额:$12.5万
-
财政年份:1997
-
负责人:CHI V. DANG
-
依托单位:
C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:3201669
-
项目类别:
-
资助金额:$23.34万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
C-MYC TARGETS IN THE PATHOGENESIS OF HUMAN CANCERS
-
批准号:3201668
-
项目类别:
-
资助金额:$22.4万
-
财政年份:1992
-
负责人:CHI V. DANG
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: